Cocoa Krispies-loving hamsters could be a key to cracking long Covid

If they genuinely mimic long Covid in humans, the hamsters could allow researchers to explore the basic biology of the disease. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        Are these Cocoa Krispies-loving hamsters a key to cracking long Covid? By Jason Mast Adobe New research shows hamster models of long Covid mimic some symptoms and molecular changes observed in humans and point to several plausible explanations for the disease. If further research bears out the results, these hamsters and several other groups of animals at other labs could allow scientists to probe the basic biology of the mysterious disease. Read More Sponsor content by Genentech Responsible drug pricing means increased transparency and action from all healthcare stakeholders There is a lack of transparency in our healthcare system, complicating true drug pricing reform. More than 50% of the costs of medicines to patients are not associated with the medicines themselves. Mindful pricing decisions must strike the right balance between substantially lower costs for patients while preserving scientific innovation. Learn about Genentech’s commitments to pricing and payment reforms that will ensure patients in the US have affordable, equitable, and sustainable access to life-changing medicines. More great reads from STAT this week If Roe is overturned, the ripples could affect IVF and genetic testing of embryos, experts warn By Andrew Joseph How the hard lessons of the AIDS crisis are shaping the response to the monkeypox outbreak By Jason Mast The graveyard of health tech pilots: why some experiments flourish and others fizzle By Mohana Ravindranath Many Black cancer patients say they aren’t offered the chance at clinical trials, survey finds By Angus Chen Opinion: It’s time to move past Aduhelm and focus on a broader Alzheimer’s drug pipeline By Howard M. Fillit A dose of transparency by Cel-Sci does nothing to burnish its failed cancer immunotherapy By Adam Feuerstein Opinion: ‘Pink tape’ at the FDA is delaying access to contraception — again By Dana Singiser Saturday, June 11, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser